About Fachklinik Bad Bentheim
Clinical Trials at Fachklinik Bad Bentheim
During the past decade, Fachklinik Bad Bentheim conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 13 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 13 clinical trials were completed. i.e. 76.5%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fachklinik Bad Bentheim" #1 sponsor was "Pfizer" with 7 trials, followed by "Eli Lilly and Company" with 6 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "UNION therapeutics"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fachklinik Bad Bentheim"
#1 collaborator was "Dermira, Inc." with 3 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Fachklinik Bad Bentheim
According to Clinical.Site data, the most researched conditions in "Fachklinik Bad Bentheim" are
"Atopic Dermatitis" (7 trials), "Psoriasis" (7 trials), "Dermatitis, Atopic" (5 trials), "Skin Diseases" (3 trials) and "Alopecia Areata" (2 trials). Many other conditions were trialed in "Fachklinik Bad Bentheim" in a lesser frequency.
Clinical Trials Intervention Types at Fachklinik Bad Bentheim
Most popular intervention types in "Fachklinik Bad Bentheim" are "Drug" (26 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Lebrikizumab" (3 trials), "PF-04965842 100 mg" (3 trials), "PF-04965842 200 mg" (3 trials) and "Abrocitinib 200 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Fachklinik Bad Bentheim
The vast majority of trials in "Fachklinik Bad Bentheim" are
28 trials for "All" genders.
Clinical Trials Status at Fachklinik Bad Bentheim
Currently, there are NaN active trials in "Fachklinik Bad Bentheim".
undefined are not yet recruiting,
3 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Fachklinik Bad Bentheim,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Fachklinik Bad Bentheim, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".